zum Inhalt
Header Image

Sonderveranstaltung 2: The Politics of Technology: A Primer on Innovative Developments that Governments Should Embrace to Kick-Start GNP

-
Hotel Alpbacherhof
Breakout / Working Group
in englischer Sprache

Das Bestreben nationaler Staaten ist es, ihren Bürgern eine bessere Lebensqualität zu bieten. Dies betrifft vor allem einen verbesserten Zugang zur Gesundheitsfürsorge, Bildung, Verkehrswesen sowie Luxusgüter und öffentliche Einrichtungen. Diese Services sind nicht kostenlos, und die Fähigkeit europäischer Regierungen, ihre Wahlversprechen auch einzuhalten, hängt direkt damit zusammen, wie gut es ihnen gelingt, Reichtum zu schaffen.
Innerhalb eines engen Zeitrahmens am Morgen des 27. August wird unsere Arbeitsgruppe die Gesetze, Richtlinien und lokalen Traditionen beleuchten, die direkten Einfluss auf Innovation und Technologie und damit auf die Bildung von Reichtum auf nationaler Ebene haben. Insbesondere wird unsere international besetzte Sprechergruppe die Möglichkeiten nationaler Politik zur Steigerung der globalen Wettbewerbsfähigkeit untersuchen.

Vortragende

Chief Executive Officer, Cellzome AG
Secretary General, European Industrial Research Management Association - EIRMA
Representative for EU Affairs, CNC - Communications & Network Consulting AG, Brussels
Universitätsprofessor emeritus
SCK-CEN, Adviser, Applied Systems Analysis and Technology Assessment
Vice President, Technology Policy, Nokia Corporation
Chief Financial Officer, UniCredit Banca Mobiliare (UBM)
Secretary General, The European Round Table of Industrialists, Brussels Chair
Communications project manager in the pharmaceuticals development department of the Roche Group, based in Basel, Switzerland Director, Lexicon Consulting, Basel Coordination

Ph.D. David BROWN

Chief Executive Officer, Cellzome AG

 Since September 2002 President and CEO of Cellzome, an emerging Biopharmaceutical company based in Cambridge, UK, and Heidelberg, Germany
 At Cellzome, Dr. Brown has focused the company's proteomics platform to create drugs to treat Alzheimer's disease, diabetes, and inflammatory diseases.
 Dr Brown 28 years experience in major Pharma and has served with 4 of the top 10 Pharma companies: Roche, Glaxo, Pfizer and Zeneca.
 Global Head of Drug Discovery, Roche Pharma, Basel, Switzerland, where he had responsibility for the output of clinical candidate drugs from approximately 2000 scientists across Roche's 5 research sites.
 Extensive experience of pharmaceutical R&D in all phases from early discovery through clinical trials.
 Experience of leading research in all major disease areas.
 Whilst at Pfizer he was named co-inventor on the patent for Viagra and he led the team that developed Viagra through to proof of concept (clinical efficacy) in man.
 At Roche, in addition to his role in leading Discovery, Dr Brown also served on the committee responsible for clinical drug development and he was a core member of the business development committee responsible for in-licensing of products and for technology agreements and acquisitions.

Dr. Andrew DEARING

Secretary General, European Industrial Research Management Association - EIRMA

1978 Graduated from University of Oxford with Doctor of Philosophy in Chemistry.
1978-1998 Range of positions in R&D management and in corporate strategy within the Royal Dutch/Shell group of companies.
 In 1998, he was seconded to the World Business Council for Sustainable Development as Programme Director for Innovation and Technology.
 Founding member of the UNEP Steering Committees establishing the Millennium Ecosystem Assessment and the World Conservation Monitoring Centre and contributed to the third round of the Intergovernmental Panel on Climate Change
 Expert advisor to the European Commission, the OECD and several national governments on matters of innovation and industrial research policy.
 Since 2000 Secretary General, European Industrial Research Management Association - EIRMA
1980-1981 Visiting Lecturer at the University of California, San Francisco.

Dr. Hanns R. GLATZ

Representative for EU Affairs, CNC - Communications & Network Consulting AG, Brussels

 Studied law, politics and economics, University of Vienna
 Doctor of laws, University of Vienna
 MA European Studies, College of Europe in Bruges
1968 Private Office, Austrian Minister of Agriculture, Vienna
1970 Ford Europe, Governmental Affairs Office, Brussels
1979 Secretary General of the CLCA, the EU federation of national motor vehicle manufacturers associations, Brussels
1989-2009 Head, Corporate Representative Office for European Affairs, Daimler-Benz (now Daimler AG), Brussels
since 2010 Head of Brussels Office, CNC - Communications & Network Consulting AG, International

Dr. Giselher GUTTMANN

Universitätsprofessor emeritus

1963 Promotion
1959 Mitarbeiter am Institut für Psychologie Wien
1961 Assistent in Erlangen
1964 Assistent in Wien
1968 Habilitation und Berufung auf ein Extraordinariat
1972 Ordinariat für Angewandte Psychologie
1973 Ordinariat für Allgemeine Psychologie (Nachfolge Rohracher)
1975 Dekan der Philosophischen Fakultät
1976 Dekan der Grund- und Integrativwissenschaftlichen Fakultät
1983 Mitglied der Österreichischen Akademie der Wissenschaften
2000 Gründungsrektor der Universität für Humanwissenschaften in Liechtenstein

Gaston MESKENS

SCK-CEN, Adviser, Applied Systems Analysis and Technology Assessment

 Academic degrees in theoretical physics and nuclear engineering from the University of Ghent, Belgium
 Within the framework of the Project on Integration of Social Aspects into Nuclear Research (PISA) of the SCK-CEN, he is PISA Program Manager and research track leader of the 'Sustainability and Nuclear Development' project (SuND)
 He is a member of IAEA & OECD/NEA expert groups on the technical and socio-economical aspects of (nuclear) technology
 He is invited independent expert to the FORATOM Task Force on Sustainable Development, the FORATOM Climate Change Working Group and the World Nuclear Association Sustainable Development Strategy Group
 Since two years, he is the European Nuclear Society representative to the negotiations within the United Nations Framework Convention on Climate Change (UNFCCC) and to the United Nations Commission on Sustainable Development (CSD)
 As the chairman of the European Nuclear Society Program Committee, he is responsible for the ENS conference profiling and long term strategy
 Within SCK-CEN, he is project leader of the International School for Radiological Protection (isRP)

Dr. techn. Erkki ORMALA

Vice President, Technology Policy, Nokia Corporation

1974 M.Eng. Degree
1986 Dr.Tech. Degree, Helsinki University of Technology
1974-1987 Research engineer at the Technical Research Centre of Finland
1976 visiting scholar at Stanford University in the USA
1982 International Institute of Applied Systems Analysis in Austria.
1987-1999 Secretary of the Science and Technology Policy Council of Finland
 His responsibilities cover technology policy, knowledge management, university co-operation, future watch and issues relating to information society.
1999 he joined Nokia Group as Director, Technology Policy.

PhD Ferdinando SAMARIA

Chief Financial Officer, UniCredit Banca Mobiliare (UBM)

1991 BA
 2 years researching in the field of Image Processing with Olivetti Research Laboratories in Cambridge
1994 MA and PhD in Engineering from Trinity College, Cambridge University
1996 joins Credit Suisse Financial Products, London
1998 moves to UniCredito Italiano as managing director in the area of risk management

Wim PHILIPPA

Secretary General, The European Round Table of Industrialists, Brussels

 Business, marketing and law degrees
1970 Heineken Breweries in the Netherlands, management positions covering South & Central America, the Caribbean and Western Europe
1979 joined Ciba-Geigy in the Netherlands and held subsequent commercial and managerial positions in Zimbabwe and Greece
 Since 1998 appointed Secretary General of the European Round Table of Industrialists
1994-1998 Head of the European Union Relations Office of Ciba-Geigy in Brussels, subsequently ran a political and legal consultancy firm

Andrew CRAVEN

Communications project manager in the pharmaceuticals development department of the Roche Group, based in Basel, Switzerland Director, Lexicon Consulting, Basel

 Degrees in Physics and Communications
 Started communications career in radio journalism
 Later recruited into first the chemicals, then pharmaceutical industries as a communications expert
 Moderator/facilitator at senior level data-discovery and experience-sharing meetings in the areas of business, law-enforcement and politics
 Proprietor of Lexicon, a communications agency providing consultancy in the areas of strategic public and media relations, and in reputation and issue management
 Communications project manager in the pharmaceuticals development department of the Roche Group, based in Basel, Switzerland

Technologiegespräche

Timetable einblenden

26.08.2004

10:00 - 11:30Technologiebrunch gesponsert durch Tiroler ZukunftsstiftungSocial
13:00 - 14:00EröffnungPlenary
14:00 - 15:30Wo kommen wir her?Plenary
16:00 - 18:30Die Welt von MorgenPlenary
20:00 - 20:30Verantwortung für anderePlenary
20:30 - 21:30Know-how der Ersten Welt, Lösungsansätze der Dritten Welt: ein Vergleich der ErgebnissePlenary
21:30 - 23:30Abendempfang gesponsert durch Alcatel AustriaSocial

27.08.2004

09:00 - 15:30Arbeitskreis 01: Technologische Potenziale zur Erreichung der Klimaschutzziele mit oder ohne Kyoto-Protokoll-RatifizierungBreakout
09:00 - 15:30Arbeitskreis 02: Kohlenstoffarme EnergieversorgungBreakout
09:00 - 15:30Arbeitskreis 03: Neue Formen der Organisation: Best Practice-Methoden des Change Management - die Kunst, den Wandel zu managenBreakout
09:00 - 15:30Arbeitskreis 04: Grenzen überschreiten: Hürden überwinden - Disziplinen überbrücken - Kulturen überdenkenBreakout
09:00 - 15:30Arbeitskreis 05: Weltraumpolitik: eine neue strategische Herausforderung für EuropaBreakout
09:00 - 15:30Arbeitskreis 06: Von Wien nach Lissabon? - Herausforderungen für die Innovationspolitik auf EU- und nationaler Ebene im Lichte des neuen EU-Aktionsplans für Innovation und der österreichischen Bestrebungen nach einer InnovationsstrategieBreakout
09:00 - 15:30Arbeitskreis 07: Mensch und Maschine - Wechselbeziehungen in der WissensgesellschaftBreakout
09:00 - 15:30Arbeitskreis 08: Sicherheit und Identifikation: Biometrie - ist es vermessen zu vermessen?Breakout
09:00 - 15:30Arbeitskreis 09: Lost in Technology? - Frauenkarrieren in Forschung und TechnologieBreakout
09:00 - 15:30Arbeitskreis 10: Herausforderungen der WiederherstellungsmedizinBreakout
09:00 - 15:30Arbeitskreis 11: Verkehrstelematik - Chancen für eine mobile GesellschaftBreakout
09:00 - 15:30Arbeitskreis 12: MyLifeBits - Digitale Unsterblichkeit und ihre GrenzenBreakout
09:00 - 15:30Sonderveranstaltung 1: Kooperationen mit Südosteuropa - Programme, Projekte, InitiativenBreakout
09:00 - 15:30Sonderveranstaltung 2: The Politics of Technology: A Primer on Innovative Developments that Governments Should Embrace to Kick-Start GNPBreakout
09:00 - 15:30Sonderveranstaltung 3: Medical Schools in the International Context - Challenges and OpportunitiesBreakout
16:00 - 17:00Wissenschaftspolitik: die Hauptakteure in Wissenschaft und Forschung - Wettbewerb und Kooperationen, Voraussetzungen für den Erfolg "Präkompetitive Forschung"Plenary
17:00 - 18:00Wissenschaftspolitik: die Hauptakteure in Wissenschaft und Forschung - Wettbewerb und Kooperationen, Voraussetzungen für den Erfolg "Kompetitive Forschung"Plenary
20:00 - 22:00Informationstransfer und -verarbeitungPlenary

28.08.2004

09:00 - 09:45The Ig Nobel PrizesPlenary
09:45 - 10:00Alpbach 2004 - Mein persönliches ResümeePlenary
10:00 - 10:30Alpbach 2004 - Resümee Junior AlpbachPlenary
11:00 - 12:30Seeing Beyond the Light: Technik und Patientennutzen am Beispiel der molekularen BildgebungPlenary
12:30 - 13:15SchlussreferatPlenary
13:30 - 14:00Schlussempfang gesponsert durch Microsoft ÖsterreichSocial